Prediction Model for Cereblon Expression in Bone Marrow Plasma Cells Based on Blood Markers in Multiple Myeloma Patients

BACKGROUND: Cereblon (CRBN) is a direct target of immunomodulatory drugs (IMiDs) and is known to be sensitive and responsive to IMiD therapy. We evaluated CRBN expression in bone marrow plasma cells and analyzed whether CRBN expression was associated with multiple myeloma prognosis. Lastly, we devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Byung-Hyun, Kang, Ka-Won, Jeon, Min Ji, Yu, Eun Sang, Kim, Dae Sik, Lee, Se Ryeon, Sung, Hwa Jung, Park, Yong, Choi, Chul Won, Kim, Byung Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316857/
https://www.ncbi.nlm.nih.gov/pubmed/34336672
http://dx.doi.org/10.3389/fonc.2021.687361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316857/
https://www.ncbi.nlm.nih.gov/pubmed/34336672
http://dx.doi.org/10.3389/fonc.2021.687361

Ejemplares similares